Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer - Top-Institutions - MDSpire

Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer

  • By

  • Manas Ranjan Sahu

  • Venu Akkanapally

  • Partha Sarathi Dasgupta

  • Sujit Basu

  • May 28, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Schepens Eye Research Institute of Harvard Medical School
    Schepens Eye Research Institute of Harvard Medical School

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Oncology

  • #2

    National Taiwan University College of Medicine
    National Taiwan University College of Medicine

    Taipei, Taiwan

    Key Differentiators

    • Medicine
    • Oncology

  • #3

    Nano Research
    Nano Research

    Unknown, Unknown

    Key Differentiators

    • Research

  • #4

    USC Keck School of Medicine
    USC Keck School of Medicine

    Los Angeles, CA

    Key Differentiators

    • Medicine
    • Oncology

  • #5

    Roski Eye Institute
    Roski Eye Institute

    Los Angeles, CA

    Key Differentiators

    • Ophthalmology
    • Oncology

Original Source(s)

Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer

  • by Manas Ranjan Sahu, Venu Akkanapally, Partha Sarathi Dasgupta, Sujit Basu

  • May 28, 2026

Related Content

Advanced Brain Tumor Care, Close to Home

  • by

  • May 28, 2026

  • 2 min
TAILORx and RxPONDER Trials Shift to a Discovery Platform

The ECOG-ACRIN Cancer Research Group, in collaboration with the SWOG Cancer Research Network, has launched a new initiative to analyze paired original and recurrent tumor specimens from two practice-c...

Roving Reporter Asks: Where Is Real Progress Being Made in Manufacturing and Supply Chain?

IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore how automation, AI, closed systems, and smarter supply chain models are helping advanced therapies move toward scalable delivery

  • May 28, 2026

  • 1 min